Close Menu
Home › Natera's Q1 Revenues Jump 31 Percent

Natera's Q1 Revenues Jump 31 Percent

May 10, 2016

NEW YORK (GenomeWeb) – Natera's first quarter 2016 revenues increased 31 percent over the first quarter of 2015, the company said after the close of the market on Tuesday.

Natera generated total revenues of $61.9 million in the first quarter 2016, up from $47.4 million in the first quarter of 2015. It beat analysts' average estimate of $48.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

What's Popular?

In Sequencing

  1. Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics

  2. Adaptive Biotechnologies Expects Planned IPO to Fetch $15 to $17 a Share

  3. At ESHG, Researchers Present New Noninvasive Prenatal Tests, Disease Recurrence Risk Study

  4. Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

  5. Metagenomic CSF Sequencing Improves Diagnosis of Neurological Infections, UCSF Study Finds

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.